COVID-19 vaccination of children aged 6 months to 4 years: JCVI advice, 9 December 2022 (updated 26 April 2023)
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination for children aged 6 months to 4 years.
Documents
Details
JCVI advises children aged 6 months to 4 years in a clinical risk group should be offered 2 3-microgram doses of the Pfizer-BioNTech COVID-19 vaccine.
Further advice regarding a potential third 3-microgram dose of the Pfizer-BioNTech COVID-19 vaccine will be issued in due course.
JCVI does not currently advise COVID-19 vaccination of children aged 6 months to 4 years who are not in a clinical risk group.
JCVI has previously offered advice regarding the vaccination of children aged 5 to 11.
Last updated 3 May 2023 + show all updates
-
Updated to remove the minimum interval of 4 weeks between any vaccine dose and recent SARS-COV-2 infection from the 'Advice' section. This advice was registered in the Green Book on 26 April 2023.
-
First published.